Pentwater Capital Management’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Pentwater Capital Management’s Portfolio CBMG Stock Details CBMG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-110,000	Closed	-$2.02M	–	407
2020 Q4	$2.02M	Buy	110,000 +34,888	+46%	+$636K	0.02%	127
2020 Q3	$1.38M	Buy	+75,112	New	+$1.26M	0.02%	141

Pentwater Capital Management's CBMG Position: Q1 2021 in Review

Pentwater Capital Management sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 110,000 shares — an estimated $2.02M sold.

Pentwater Capital Management first reported a position in CBMG in Q3 2020 and held it in 2 quarters. The position peaked at $2.02M in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

Pentwater Capital Management reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
Pentwater Capital Management sold 110,000 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $2.02M.
Pentwater Capital Management first reported a position in Cellular Biomedicine Group, Inc. in Q3 2020 and held it in 2 quarters.
Pentwater Capital Management's Cellular Biomedicine Group, Inc. position peaked at $2.02M in Q4 2020.
0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Pentwater Capital Management's 13F filing for Q1 2021, filed 17 May 2021.